STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Q1
• Results from Phase I study in cancer pain shows promising safety data and relief of chronic pain
Q2 • Recruitment for US Phase III study in type 1 diabetes is completed • Phase II study in cancer pain is started • University of Florida Research Foundation initiates court case against Diamyd Medical (STO:DIAM.B)
